3,4-Difluoroiodobenzene: Handling, Uses & Lab Protocol

3,4-Difluoroiodobenzene is a versatile difluorinated aryl iodide building block widely employed in palladium- and copper-catalyzed cross-coupling reactions for the synthesis of fluorinated biaryl compounds and pharmaceutical intermediates.

CAS Number

36282-29-8

Molecular Formula

C₆H₃F₂I

Molecular Weight

239.99 g/mol

Appearance

Colorless to pale yellow liquid

Primary Application

Electrophilic partner in Pd- and Cu-catalyzed cross-coupling reactions

Storage Conditions

Store in a cool, dry, well-ventilated area away from light and moisture

SKU

D115538

Overview and Chemical Properties

3,4-Difluoroiodobenzene (CAS 36282-29-8) is a halogenated aromatic compound bearing two fluorine substituents at the 3- and 4-positions and an iodo group as the primary reactive site. Its molecular formula is C₆H₃F₂I with a molecular weight of approximately 239.99 g/mol. The compound typically presents as a colorless to pale yellow liquid at room temperature.

The carbon–iodine bond is significantly more reactive than carbon–bromine or carbon–chlorine bonds in oxidative addition steps, making aryl iodides such as this compound particularly efficient coupling partners under mild palladium- or copper-catalyzed conditions. The two electron-withdrawing fluorine atoms additionally modulate the electron density of the aromatic ring, influencing regioselectivity and reactivity in downstream transformations.

The incorporation of fluorine atoms into drug-like molecules is a well-established medicinal chemistry strategy that can improve metabolic stability, membrane permeability, and binding affinity. As a result, 3,4-Difluoroiodobenzene is valued as a key building block in pharmaceutical and agrochemical research.

Safety and Handling Guidelines

Before working with 3,4-Difluoroiodobenzene, consult the current Safety Data Sheet (SDS) provided with your shipment. Observe the following precautions:

• Personal Protective Equipment (PPE): Wear chemical-resistant gloves (e.g., nitrile or neoprene), a laboratory coat, and safety goggles. When handling larger quantities or working in confined spaces, use a full-face shield.
• Ventilation: All operations must be performed in a well-functioning fume hood. The compound may release irritating vapors.
• Skin and Eye Contact: In case of skin contact, wash immediately with soap and water for at least 15 minutes. For eye contact, rinse with copious water and seek medical attention promptly.
• Ingestion/Inhalation: Do not eat, drink, or smoke in the work area. If inhalation occurs, move to fresh air immediately and seek medical attention if symptoms persist.
• Waste Disposal: Dispose of waste in accordance with local, regional, and national regulations for halogenated organic solvents and reagents.

Store the compound in a tightly sealed container in a cool (2–25 °C), dry, well-ventilated area, protected from light and moisture. Keep away from strong oxidizing agents and bases.

Step-by-Step Protocol: Suzuki–Miyaura Cross-Coupling

The following general protocol describes the use of 3,4-Difluoroiodobenzene as the aryl halide electrophile in a Suzuki–Miyaura coupling reaction with an arylboronic acid. Adjust reagent ratios and conditions based on your specific substrate and literature precedent.

Materials Required

• 3,4-Difluoroiodobenzene (D115538, 1.0 equiv)
• Arylboronic acid (1.1–1.5 equiv)
• Palladium catalyst (e.g., Pd(PPh₃)₄ or Pd(dppf)Cl₂, 1–5 mol%)
• Base (e.g., K₂CO₃ or Cs₂CO₃, 2.0–3.0 equiv)
• Solvent system (e.g., DMF/H₂O, THF/H₂O, or dioxane/H₂O, 4:1 v/v)
• Inert gas supply (nitrogen or argon)
• Magnetic stir bar, round-bottom flask, reflux condenser, syringe/cannula

Procedure

1. Preparation: Oven-dry all glassware and cool under inert gas. Degas the solvent system by sparging with nitrogen or argon for at least 15 minutes.
2. Charging the flask: Under inert atmosphere, add the palladium catalyst, arylboronic acid, and base to a flame-dried round-bottom flask containing a magnetic stir bar.
3. Addition of substrate: Add the degassed solvent, followed by 3,4-Difluoroiodobenzene (neat or as a solution) via syringe.
4. Reaction: Seal the flask with a rubber septum, and stir at 80–100 °C (oil bath) for 12–18 hours under inert atmosphere. Monitor reaction progress by TLC or analytical HPLC.
5. Workup: Allow the reaction to cool to room temperature. Dilute with ethyl acetate and wash sequentially with water and brine. Dry the organic layer over anhydrous Na₂SO₄ or MgSO₄, filter, and concentrate under reduced pressure.
6. Purification: Purify the crude product by column chromatography (silica gel) or recrystallization as appropriate. Confirm identity and purity by ¹H NMR, ¹⁹F NMR, and/or LC-MS.

Note: Catalyst loading, base, solvent, and temperature should be optimized for each specific substrate combination. Consult primary literature for analogous substrates.

Applications in Research

3,4-Difluoroiodobenzene serves as a valuable synthetic building block across multiple research domains:

• Medicinal Chemistry: Used to introduce a 3,4-difluorophenyl motif into drug candidates, where the gem-difluoro pattern can enhance metabolic stability, lipophilicity, and protein–ligand interactions.
• Suzuki–Miyaura Coupling: Reacts with arylboronic acids or esters under Pd catalysis to afford fluorinated biaryl products, which are prevalent scaffolds in approved pharmaceuticals.
• Sonogashira Coupling: Couples with terminal alkynes in the presence of Pd/Cu catalyst systems to produce fluorinated aryl alkynes useful in materials science and medicinal chemistry.
• Buchwald–Hartwig Amination: Acts as the aryl halide component in Pd-catalyzed C–N bond forming reactions for the synthesis of fluorinated arylamines.
• Ullmann-Type and Cu-Catalyzed Reactions: Participates in copper-mediated etherification, amination, and thioetherification reactions.
• Materials Science: Incorporated as a fluorinated arene unit in the synthesis of organic semiconductors, liquid crystals, and functional polymers where C–F bonds contribute to specific electronic and structural properties.

Troubleshooting and Best Practices

The following guidance addresses common challenges encountered when using 3,4-Difluoroiodobenzene in cross-coupling protocols:

• Low Conversion: Ensure complete exclusion of oxygen and moisture, as trace amounts can deactivate palladium catalysts. Re-degas solvents and reagents if reactions are run over extended periods. Increase catalyst loading (up to 5 mol%) or switch to a more active catalyst (e.g., Pd₂(dba)₃ with a bidentate phosphine ligand).
• Homocoupling Byproducts: Aryl iodides can undergo homocoupling under certain conditions. Minimize by using freshly prepared catalyst solutions, controlled addition of reagents, and rigorous inert atmosphere technique.
• Protodeiodination: If significant quantities of the defluorinated or deiodinated arene are observed, lower the reaction temperature or adjust the base to reduce competing side reactions.
• Poor Solubility: If reagents are poorly soluble in the chosen solvent, consider switching to DMF, NMP, or adding co-solvents. Ensure thorough mixing before heating.
• Product Purification: Fluorinated biaryls can be challenging to separate from starting materials by TLC alone; use HPLC monitoring. Gradient elution during column chromatography (hexane/EtOAc) is typically effective.
• Reagent Purity: Use high-purity 3,4-Difluoroiodobenzene (D115538) to avoid catalyst poisoning from trace impurities. Check purity by GC or NMR before use in sensitive transformations.

Frequently asked questions

What is 3,4-Difluoroiodobenzene used for in organic synthesis?

3,4-Difluoroiodobenzene is primarily used as an electrophilic aryl halide building block in palladium- and copper-catalyzed cross-coupling reactions, including Suzuki–Miyaura, Sonogashira, and Buchwald–Hartwig reactions. It enables the efficient introduction of the 3,4-difluorophenyl group into target molecules for pharmaceutical, agrochemical, and materials science applications.

Why is an aryl iodide preferred over an aryl bromide or chloride in cross-coupling reactions?

The carbon–iodine bond has a lower bond dissociation energy than C–Br or C–Cl bonds, making aryl iodides more reactive in the oxidative addition step of the palladium catalytic cycle. This allows reactions to proceed under milder conditions, with lower catalyst loadings, and often with broader substrate tolerance compared to the corresponding aryl bromides or chlorides.

How should 3,4-Difluoroiodobenzene be stored to maintain its quality?

Store 3,4-Difluoroiodobenzene in a tightly sealed container at cool temperatures (2–25 °C), protected from light and moisture, and away from strong oxidizing agents and bases. Verify purity by GC or NMR before use in sensitive reactions, especially if the reagent has been stored for an extended period.

What palladium catalysts are recommended for cross-coupling reactions with 3,4-Difluoroiodobenzene?

Commonly used palladium catalysts include Pd(PPh₃)₄, Pd(dppf)Cl₂, and Pd₂(dba)₃ combined with an appropriate phosphine ligand. The optimal choice depends on the specific reaction type and coupling partner; Pd(PPh₃)₄ is a reliable starting point for Suzuki–Miyaura couplings, while more hindered or electron-rich substrates may benefit from bulky phosphine-ligated palladium catalysts.

Is 3,4-Difluoroiodobenzene compatible with copper-catalyzed reactions?

Yes, 3,4-Difluoroiodobenzene is compatible with copper-catalyzed Ullmann-type reactions, including C–O, C–N, and C–S bond forming reactions. These reactions typically require higher temperatures and stoichiometric or catalytic copper with an appropriate ligand, but aryl iodides are the most reactive aryl halide class in copper-catalyzed couplings.

References

1. Miyaura, N.; Suzuki, A. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds. Chemical Reviews 1995, 95, 2457–2483. doi:10.1021/cr00039a007
2. Sonogashira, K. Development of Pd–Cu catalyzed cross-coupling of terminal acetylenes with sp2-carbon halides. Journal of Organometallic Chemistry 2002, 653, 46–49. doi:10.1016/S0022-328X(02)01158-0
3. Muci, A. R.; Buchwald, S. L. Practical Palladium Catalysts for C–N and C–O Bond Formation. Topics in Current Chemistry 2002, 219, 131–209. doi:10.1007/3-540-45313-X_5
4. Hagmann, W. K. The Many Roles for Fluorine in Medicinal Chemistry. Journal of Medicinal Chemistry 2008, 51, 4359–4369. doi:10.1021/jm800219f

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.